These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


388 related items for PubMed ID: 32013731

  • 1. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
    Lindblad C, Nelson DW, Zeiler FA, Ercole A, Ghatan PH, von Horn H, Risling M, Svensson M, Agoston DV, Bellander BM, Thelin EP.
    J Neurotrauma; 2020 Jun 15; 37(12):1381-1391. PubMed ID: 32013731
    [Abstract] [Full Text] [Related]

  • 2. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M, Dreßler J, Franke H, Pohlers D, Ondruschka B.
    J Forensic Leg Med; 2018 Apr 15; 55():65-73. PubMed ID: 29471249
    [Abstract] [Full Text] [Related]

  • 3. Development of a strategy for assessing blood-brain barrier disruption using serum S100 calcium-binding protein B and neuron-specific enolase in early stage of neuroemergencies: A preliminary study.
    Yun GS, In YN, Kang C, Park JS, You Y, Min JH, Ahn HJ, Yoo I, Kim SW, Oh SK, Lee IH, Kim DM.
    Medicine (Baltimore); 2022 Jul 15; 101(28):e29644. PubMed ID: 35839066
    [Abstract] [Full Text] [Related]

  • 4. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
    Thelin EP, Jeppsson E, Frostell A, Svensson M, Mondello S, Bellander BM, Nelson DW.
    Crit Care; 2016 Sep 08; 20():285. PubMed ID: 27604350
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH, Hwang SK.
    World Neurosurg; 2018 Oct 08; 118():e534-e542. PubMed ID: 30257306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, Stöcklein V, Bazarian JJ.
    J Neurotrauma; 2009 Sep 08; 26(9):1497-1507. PubMed ID: 19257803
    [Abstract] [Full Text] [Related]

  • 8. Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B.
    Bellander BM, Olafsson IH, Ghatan PH, Bro Skejo HP, Hansson LO, Wanecek M, Svensson MA.
    Acta Neurochir (Wien); 2011 Jan 08; 153(1):90-100. PubMed ID: 20686797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C, Pin E, Just D, Al Nimer F, Nilsson P, Bellander BM, Svensson M, Piehl F, Thelin EP.
    Crit Care; 2021 Mar 12; 25(1):103. PubMed ID: 33712077
    [Abstract] [Full Text] [Related]

  • 11. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM.
    Pediatrics; 2002 Feb 12; 109(2):E31. PubMed ID: 11826241
    [Abstract] [Full Text] [Related]

  • 12. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
    Liu B, Xie Z, Liu G, Gu Y, Pan S, Wang H.
    Clin Chim Acta; 2018 May 12; 480():79-83. PubMed ID: 29329729
    [Abstract] [Full Text] [Related]

  • 13. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
    Ondruschka B, Pohlers D, Sommer G, Schober K, Teupser D, Franke H, Dressler J.
    J Neurotrauma; 2013 Nov 15; 30(22):1862-71. PubMed ID: 23796187
    [Abstract] [Full Text] [Related]

  • 14. Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia.
    Friis T, Wikström AK, Acurio J, León J, Zetterberg H, Blennow K, Nelander M, Åkerud H, Kaihola H, Cluver C, Troncoso F, Torres-Vergara P, Escudero C, Bergman L.
    Cells; 2022 Feb 24; 11(5):. PubMed ID: 35269411
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ, Farahvar A, He H, Nayak A, Yang C, Shaw G, Bazarian JJ.
    J Neurotrauma; 2011 Dec 24; 28(12):2453-62. PubMed ID: 21428722
    [Abstract] [Full Text] [Related]

  • 16. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
    Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, Warsz-Wianecka A, Zareba K, Puz P, Bal W, Pawletko K, Lewin-Kowalik J.
    J Physiol Pharmacol; 2019 Apr 24; 70(2):. PubMed ID: 31356182
    [Abstract] [Full Text] [Related]

  • 17. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I, Kleindienst A, Hore N, Buchfelder M, Brandner S.
    Clin Neurol Neurosurg; 2016 Jun 24; 145():79-83. PubMed ID: 27101088
    [Abstract] [Full Text] [Related]

  • 18. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
    Baker AJ, Rhind SG, Morrison LJ, Black S, Crnko NT, Shek PN, Rizoli SB.
    J Neurotrauma; 2009 Aug 24; 26(8):1227-40. PubMed ID: 19637968
    [Abstract] [Full Text] [Related]

  • 19. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
    Stein DM, Kufera JA, Lindell A, Murdock KR, Menaker J, Bochicchio GV, Aarabi B, Scalea TM.
    Neurocrit Care; 2011 Apr 24; 14(2):200-7. PubMed ID: 21210304
    [Abstract] [Full Text] [Related]

  • 20. Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value.
    Gao Y, Duan J, Ji H, Lu W.
    Ann Palliat Med; 2021 Mar 24; 10(3):3371-3378. PubMed ID: 33849122
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.